Wendy Beranek, in Durant, OK - Psychologist

Wendy Beranek, is a Psychologist - Rehabilitation based in Durant, Oklahoma. Wendy Beranek is licensed to practice in * (Not Available) (license number ) and her current practice location is 103 N 3rd Ave, Durant, Oklahoma. She can be reached at her office (for appointments etc.) via phone at (580) 745-9276.

NPI number for Wendy Beranek is 1154507259 and her current mailing address is Po Box 1030, Antlers, Oklahoma. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1154507259.

Contact Information

	Wendy Beranek,
	103 N 3rd Ave, Durant, OK 74701-4700
	(580) 745-9276
	Not Available

Healthcare Provider's Profile

Full Name	Wendy Beranek
Gender	Female
Speciality	Psychologist - Rehabilitation
Location	103 N 3rd Ave, Durant, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1154507259
Provider Enumeration Date: 01/18/2008
Last Update Date: 06/05/2012

Medical Identifiers

Medical identifiers for Wendy Beranek such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1154507259	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103TR0400X	Psychologist - Rehabilitation	(* (Not Available))	Primary
171M00000X	Case Manager/care Coordinator	(* (Not Available))	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Wendy Beranek is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Wendy Beranek, Po Box 1030, Antlers, OK 74523-1030 Ph: (580) 298-2830	Wendy Beranek, 103 N 3rd Ave, Durant, OK 74701-4700 Ph: (580) 745-9276

News Archive

BIA to exhibit new in-house software platform at 2010 Legaltech conference

Business Intelligence Associates, Inc. (BIA), a legal software and services industry leader, announced today that they will be exhibiting their new in-house ESI Management software product, Solis™, at ALM's LegalTech® New York 2010 from February 1-3, 2010 (Booth #1720).

Concord Coalition sends list of suggestions concerning the healthcare reform bill

In the coming days, you have the unenviable task of combining the Senate Finance Committee's health care reform bill with the bill that emerged from the Health, Education, Labor and Pensions Committee. Aware of the difficulty and the competing pressures you face, we have identified in the attached memorandum key areas where we believe the potential of the legislation to produce fiscal gains can be strengthened. We hope our views will help guide your work - consistent with fiscal responsibility and sustainability.

Research findings may help scientists develop anthrax treatments for humans

Researchers at the National Institute of Allergy and Infectious Diseases and the National Heart, Lung, and Blood Institute, both part of the National Institutes of Health, have identified the cells in two distinct areas of the body that are simultaneously targeted for damage by anthrax toxins, eventually causing illness and sometimes death. Their findings, which appeared online today in Nature, are based on testing in mice.

Dysautonomia linked to CKD: Study

Individuals with a high resting heart rate and a low beat-to-beat heart rate variability have an increased risk of developing kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The findings suggest that the behavior of the autonomic nervous system may be a sentinel marker for late development of certain cases of kidney disease.

Less-toxic drug combined with fasting may kill cancer cells

Fasting in combination with chemotherapy has already been shown to kill cancer cells, but a pair of new studies in mice suggests that a less-toxic class of drugs combined with fasting may kill breast, colorectal and lung cancer cells equally well.

Wendy Beranek, - Psychologist in Durant, OK